Abstract 930: Preclinical characterization of MG516, a novel inhibitor of receptor tyrosine kinases involved in resistance to targeted therapies by Beaulieu, Normand, Sainte-Croix, Helene, Bonfils, Claire, Mannion, Michael, Raeppel, Stephane, Isakovic, Lubo, Claridge, Stephen, Saavedra, Oscar, Raeppel, Franck, Vaisburg, Arkadii, Wang, James, Fournel, Marielle, Besterman, Jeffrey M., Maroun, Christiane R.

Get full text